SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin

Seong Joon Park, Seung-Mi Kim, Jai-Hee Moon, Jeong Hee Kim, Jae-Sik Shin, Seung-Woo Hong, Yu Jin Shin, Dae-Hee Lee, Eun Young Lee, Ih-Yeon Hwang, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Won–Keun Lee, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim
  • Tumor Biology, October 2015, Springer Science + Business Media
  • DOI: 10.1007/s13277-015-4216-2

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1007/s13277-015-4216-2

In partnership with: